Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Inizio

Website
Email
+44 020 3861 3999

Inizio is your market-leading commercialization partner.

We provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Leveraging our connected suite of capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle, creating solutions that simplify the complex, unlock value, and enhance treatment outcomes.

6th Floor, Holborn Gate, 26 Southampton Buildings, WC2A 1AN United Kingdom

At the heart of our success are the talented experts who work hand-in-hand with our clients to deliver exceptional value, innovation, and impact. Explore our latest awards, achievements, and recognitions as we continue to set new standards and reimagine the future of health here.

 

With >10,500 specialists across >50 countries, we unite global reach with deep, broad expertise in science, strategy, creativity, and technology. Our work spans all 14 therapeutic areas, and we’re proud to support every one of the top 20 pharmaceutical companies worldwide. What sets us apart is how we bring our capabilities together, across five areas of our business:

 

Inizio Advisory

Inizio Advisory partners with global life science and healthcare companies to create lasting change in human healthcare.

Across four businesses in market research (Research Partnership), strategic consulting (Putnam), management consulting (Vynamic), and brand alignment (STEM), Inizio Advisory support clients at every stage of the product and patient journey, accelerating clinical and commercial success and long-term value.

 

Inizio Medical

Inizio Medical connects scientific expertise and technology to create compelling content and experiences that inform, inspire, and engage medical communities globally.

Inizio Medical brings together three of the most recognized and trusted global medical communications agencies – ApotheCom, Ashfield MedComms and Nucleus Global –  underpinned with best-in-class Medical Affairs consulting, data analytics, integrated evidence generation, and industry-leading AI solutions through medical excellence and transformation agency, MEDiSTRAVA.

 

Inizio Evoke

Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insight and human centricity.

Inizio Evoke – a full-service team of creative problem solvers who always find a way to make health more human™ – is built to design intuitive, people-centric experiences, brands, and businesses that drive transformative growth across brand and creative, communications, transformation, access, and media.

 

Inizio Engage

Inizio Engage is a global strategic, commercial, and creative engagement partner.

Combining a unique mix of consultation, creation, and activation expertise with the latest technology, Inizio Engage design and deliver tailored solutions that inspire lasting change across decision optimization, experience design (XD), patient solutions, Medical Affairs, and commercial.

 

Inizio Biotech

Inizio Biotech develops personalized solutions curated to maxmise asset value at every opportunity.

Providing best-in-class services across the clinical development and commercialization journey, our biotech solutions are highly personalized and coordinated through a single strategic point of contact. Inizio Biotech support you by guiding, validating, and inspiring the decisions that matter most.

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...

ALL PRESS RELEASES

The value of design thinking: Incorporating creative and graphic design into pharma market research

How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking?There...

Research Partnership launches new patient Living with Psoriasis 2017 (EU) report

Living with Psoriasis is a study conducted amongst 615 patients in Europe. The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. It can be purchased...

Deep Dive – MINT: opportunities in ‘frontier’ markets?

According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are...

Webcast: Going for growth – Maximising your return on insights in Emerging Markets

Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Healthcare market research in emerging...

20 questions: Round 6

As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month we asked our employees about office life in Singapore.Watch the video: https://www.researchpartnership.com/news/2017/09/20-questions-round-6/

Ageing Asia: What does this mean for the future of healthcare?

Over the last 30 years, Asia’s economic growth has resulted in improved education and healthcare across a broad base of the population. This has contributed to declining fertility and increasing...

Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations

Segmentation solutions in healthcare are experiencing a welcome comeback. But there appear to be two camps emerging - one camp are proponents of the 'behavioural' segmentation based on secondary sales,...

Qualitative segmentation validation study with backroom brainstorm exercises

Our client had an oncology product in development for the treatment of prostate cancer. The company wanted to conduct research to inform future planning, list development, advisory board creation, and...

PMRC EU, Düsseldorf 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 24-25 October in Düsseldorf, GermanyDirector, Anne Cunningham, and Associate Director, Nicky Barclay-Prout, are representing...

Device Attribute Testing

Our client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones.  They also wanted to...

ALL WHITE PAPERS

Reimagine health with Inizio.

At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

PEGASUS SHOWREEL 2017

What we do and who we do it for | Pegasus

We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

Understanding decision making in health | Pegasus

To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

An animated approach to communicating healthy messages | Pegasus

Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

ALL VIDEOS AND PODCASTS

At Inizio, sustainability means minimizing our environmental impact, championing inclusion, promoting health equity, and operating in a responsible, ethical manner that allows us to grow in a way that benefits all our stakeholders.

Guided by our Commitments, our people are empowered to make a real difference. In our latest report, we’re proud to present the significant progress we made in 2024. Read our 2024 Sustainability Report. 

Ryan Quigley

Ryan Quigley
CEO, Inizio

Gavin McShera

Gavin McShera
Chief Information Officer, Inizio

Mary-Kate McGarry

Mary-Kate McGarry
Chief Strategy & Innovation Officer, Inizio

Ben Jackson

Ben Jackson
CFO, Inizio

Colin Stanley

Colin Stanley
CCO, Inizio

Grainne McAleese

Grainne McAleese
Deputy CFO, Inizio

Stephanie Hasenbos-Case

Stephanie Hasenbos-Case
Chief Human Resources Officer, Inizio

Remco op den Kelder

Remco op den Kelder
President, Inizio Advisory

Elaine Ferguson

Elaine Ferguson
Global President, Inizio Medical

Reid Connolly

Reid Connolly
Global President, Inizio Evoke

Jim Sage

Jim Sage
Global President, Inizio Engage

Company Details

- PMLiVE

Email
Website

 Latest Content from  Inizio 

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

Preparing for ASH 2025: Pharma’s role in hematology innovation

As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...

AI without limits: A smarter, integrated approach to Medical Affairs

At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...